To market your product/ingredient it is essential to prove it does not cause contact allergy reactions to the future users.
The HRIPT* is a clinical final security test under dermatological control, allowing to confirm that repeated applications of a cosmetic or pharmaceutical product under maximised conditions, does not induce delayed contact allergy reactions on the subjects participating in the study.
It also aims to determine the irritating and sensitising potential of the product after repeated application.
In collaboration with our toxicologists’ experts, the HRIPT enables after evaluating your formula, to claim the hypoallergenic feature.
You want to know more about this test or include your product on one of our regular or exclusive panels? Please contact us immediately!
- For cosmetic product: commercial@dermscan.com
- For pharmaceutical product: commercial@pharmascan.fr
